Radient Pharmaceuticals Corp announced diagnostics development and commercialization firm Provista Life Sciences LLC (PLS) has independently validated Radient Pharmaceuticals’ Onko-Sure in vitro diagnostic (IVD) cancer test.
Read More
Personalized medicine is not perfect, but it is personal. CLP looks at some new tests on the market to see how personal they are.
Read MoreClovis Oncology Inc and Ventana Medical Systems Inc announced that they have entered into a collaboration agreement for the development of a human equilibrative nucleoside transporter 1 (hENT1) immunohistochemistry (IHC) assay.
Read MoreThrough its US-based subsidiary AMDL Diagnostics Inc, Radient Pharmaceuticals Corp announced that it plans to expand its worldwide commercialization strategy for its Onko-Sure in vitro diagnostic cancer test to include CLIA laboratory testing services.
Read MoreQIAGEN has announced the appointment of two high level members, Dr Pia Garguilo and Richard Watts, to the recently formed Pharma Business Development team.
Read More